Precision Medicine Online: UC launches clinical trial for post-spinal surgery pain management
Precision Medicine Online highlighted a University of Cincinnati Gardner Neuroscience Institute clinical trial applying a personalized approach to pain management that doctors hope can improve post-surgical pain, reduce opioid dependence and reduce length of hospital stays.
More than half of patients who undergo spine surgery report poor pain control, and between 30 and 50 percent experience chronic pain for longer than 12 weeks (the time of routine tissue healing) following surgery.
Led by the University of Cincinnati's Owoicho Adogwa, MD, the trial takes patients' blood and saliva samples to see how their unique genes respond to different medications.
"Drug reactions vary significantly among individuals," Adogwa, assistant professor of neurosurgery in UC's College of Medicine, told Precision Medicine Online. "In spine surgery, traditional 'one size fits all' pain management is often inadequate due to genetic variations in drug metabolism."
Adogwa said early results of the trial have been encouraging, including shorter hospital stays for patients in the active arm of the trial.
Read the Precision Medicine Online story.
Featured photo at top of Dr. Adogwa in surgery. Photo/UC Health.
Related Stories
Sugar overload killing hearts
November 10, 2025
Two in five people will be told they have diabetes during their lifetime. And people who have diabetes are twice as likely to develop heart disease. One of the deadliest dangers? Diabetic cardiomyopathy. But groundbreaking University of Cincinnati research hopes to stop and even reverse the damage before it’s too late.
Is going nuclear the solution to Ohio’s energy costs?
November 10, 2025
The Ohio Capital Journal recently reported that as energy prices continue to climb, economists are weighing the benefits of going nuclear to curb costs. The publication dove into a Scioto Analysis survey of 18 economists to weigh the pros and cons of nuclear energy. One economist featured was Iryna Topolyan, PhD, professor of economics at the Carl H. Lindner College of Business.
App turns smartwatch into detector of structural heart disease
November 10, 2025
An app that uses an AI model to read a single-lead ECG from a smartwatch can detect structural heart disease, researchers reported at the 2025 Scientific Sessions of the American Heart Association. Although the technology requires further validation, researchers said it could help improve the identification of patients with heart failure, valvular conditions and left ventricular hypertrophy before they become symptomatic, which could improve the prognosis for people with these conditions.